Prevalence and Outcomes Associated with Vitamin D Deficiency among Indexed Hospitalizations with Cardiovascular Disease and Cerebrovascular Disorder-A Nationwide Study
Medicines (Basel). 2020 Nov 22;7(11):E72. doi: 10.3390/medicines7110072.
Urvish Patel 1, Salma Yousuf 1, Komal Lakhani 2, Payu Raval 3 4, Nirmaljot Kaur 5, Toochukwu Okafor 6, Chail Shah 7 8, Harmandeep Singh 5, Mehwish Martin 1, Chika Nwodika 9, Angelina Yogarajah 10, Jigisha Rakholiya 11, Maitree Patel 12, Raja Chandra Chakinala 13, Shamik Shah 14
Background: According to past studies, recovery and survival following severe vascular events such as acute myocardial infarction and stroke are negatively impacted by vitamin D deficiency. However, the national estimate on disability-related burden is unclear. We intend to evaluate the prevalence and outcomes of vitamin D deficiency (VDD) among patients with cardiovascular disease (CVD) and cerebrovascular disorder (CeVD).
Methods: We performed a cross-sectional study on the Nationwide Inpatient Sample data (2016-2017) of adult (≥18 years) hospitalizations. We identified patients with a secondary diagnosis of VDD and a primary diagnosis of CVD and CeVD using the 9th revision of the International Classification of Diseases, clinical modification code (ICD-10-CM) codes. A univariate and mixed-effect multivariable survey logistic regression analysis was performed to evaluate the prevalence, disability, and discharge disposition of patients with CVD and CeVD in the presence of VDD.
Results: Among 58,259,589 USA hospitalizations, 3.44%, 2.15%, 0.06%, 1.28%, 11.49%, 1.71%, 0.38%, 0.23%, and 0.08% had primary admission of IHD, acute MI, angina, AFib, CHF, AIS, TIA, ICeH, and SAH, respectively and 1.82% had VDD.
The prevalence of hospitalizations due to:
- CHF (14.66% vs. 11.43%),
- AIS (1.87% vs. 1.71%), and
- TIA (0.4% vs. 0.38%)
was higher among VDD patients as compared with non-VDD patients (p < 0.0001).
In a regression analysis, as compare with non-VDD patients, the VDD patients were associated with higher odds of discharge to non-home facilities with an admission diagnosis of
- CHF (aOR 1.08, 95% CI 1.07-1.09),
- IHD (aOR 1.24, 95% CI 1.21-1.28),
- acute MI (aOR 1.23, 95% CI 1.19-1.28),
- AFib (aOR 1.21, 95% CI 1.16-1.27), and
- TIA (aOR 1.19, 95% CI 1.11-1.28).
VDD was associated with higher odds of severe or extreme disability among patients hospitalized with
- IS (aOR 1.1, 95% CI 1.06-1.14),
- ICeH (aOR 1.22, 95% CI 1.08-1.38),
- TIA (aOR 1.36, 95% CI 1.25-1.47),
- IHD (aOR 1.37, 95% CI 1.33-1.41),
- acute MI (aOR 1.44, 95% CI 1.38-1.49),
- AFib (aOR 1.10, 95% CI 1.06-1.15), and
- CHF (aOR 1.03, 95% CI 1.02-1.05) as compared with non-VDD.
Conclusions: CVD and CeVD in the presence of VDD increase the disability and discharge to non-home facilities among USA hospitalizations. Future studies should be planned to evaluate the effect of VDD replacement for improving outcomes.
Download the PDF from VitaminDWiki
Cardiovascular category is associated with other categories: Diabetes 31, Omega-3 31 , Vitamin K 25 , Intervention 22 . Mortality 20 , Skin - Dark 18 , Magnesium 17 , Calcium 14 , Hypertension 14 , Trauma and surgery 13 , Stroke 13 , Kidney 12 , Metabolic Syndrome 11 , Seniors 10 , Pregnancy 8 as of Aug 2022
- Overview Cardiovascular and vitamin D
- CAD patients with low vitamin D were 1.6 X more likely to die – 27th meta-analysis Aug 2022
- Cardiovascular Disease is treated by Vitamin D - review Oct 2021
- Arterial Stiffness and Vitamins – only Vitamin D was found to help – meta-analysis Feb 2022
- Those raising Vitamin D above 30 ng were 1.4 X less likely to die of Heart Attack (VA 19 years) – Oct 2021
- Giving free vitamin D to every Iranian would pay for itself by just reducing CVD – Oct 2021
- Sudden Cardiac Arrest – 2.8 X higher risk if low vitamin D – 2019
- Peripheral arterial disease risk is 1.5X higher if low vitamin D – meta-analysis March 2018
- Heart attack ICU costs cut in half by Vitamin D – Oct 2018
- Cardiovascular disease 2.3 X more-likely if poor Vitamin D Receptor – Aug 2022
- Cholesterol is needed to produce both Vitamin D and Cortisol
- Overview Cholesterol and vitamin D
- Statins and vitamin D statins often reduce levels of vitamin D
- Statin side-effects are reduced by Vitamin D – US patent Application – April 2019
|1456 visitors, last modified 04 Dec, 2020,